Latest Australian Industry News

Cromwell Property Group has agreed to acquire a significant stake in a $470 million Australian industrial portfolio and the management platform behind it, expanding its assets under management by approximately $540 million.

Li-S Energy has completed Australia’s inaugural lithium foil production line, marking a key step in domestic battery material manufacturing and opening export opportunities.

Pure Hydrogen Corporation has locked in a $2.5 million loan facility to accelerate its clean energy vehicle rollout, aiming to capitalise on a growing sales pipeline in Australia and the US.

Syrah Resources has secured an extension to address an alleged default under its Tesla offtake agreement, pushing the cure deadline to November 2025 as both parties work toward resolution.

Washington H. Soul Pattinson and Brickworks Limited are advancing their proposed merger with key shareholder meetings and Supreme Court hearings scheduled in September 2025.

Goodman Group has announced a total distribution of 15 cents per stapled security for the year ended 30 June 2025, combining dividends from its Hong Kong logistics arm and its Australian industrial trust.

NAOS Ex-50 Opportunities Company Limited reported a strong FY25 with a 28.92% portfolio return and maintained its annual dividend at 6.0 cents per share, reflecting robust capital management and investor confidence.

Dexus Industria REIT reported robust FY25 financials, marked by resilient income growth and strategic portfolio repositioning to 100% industrial assets. Key acquisitions and divestments, alongside a $230 million development pipeline, position the REIT for sustained growth.

Centuria Industrial REIT (ASX, CIP) reported solid FY25 financial results with robust occupancy and earnings growth, setting the stage for higher distributions and continued development in FY26.

Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.

Vitrafy Life Sciences reported strong FY25 progress with 75% sales growth, advanced cryopreservation technology development, and a robust cash position. The company outlines a clear commercialisation roadmap for FY26, including product launches and expanded U.S. operations.

SKS Technologies Group has exceeded its FY25 profit guidance, reporting a 15.6% increase in profit before tax alongside robust revenue growth and a strong cash position.